<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37773135</PMID><DateCompleted><Year>2023</Year><Month>10</Month><Day>02</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>21</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1746-6148</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Sep</Month><Day>29</Day></PubDate></JournalIssue><Title>BMC veterinary research</Title><ISOAbbreviation>BMC Vet Res</ISOAbbreviation></Journal><ArticleTitle>A meta-analysis for vaccine protection rate of duck hepatitis a virus in mainland China in 2009-2021.</ArticleTitle><Pagination><StartPage>179</StartPage><MedlinePgn>179</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">179</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12917-023-03744-8</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Duck hepatitis A virus (DHAV) is a single-stranded, positive-strand small RNA virus that causes a very high mortality rate in ducklings. The DHAV-3 subtype incidence rate has recently increased in China, causing great economic losses to the waterfowl breeding industry. We analyzed the protection rate of DHAV vaccines used in mainland China from 2009 to 2021 and evaluated the effectiveness of vaccine prevention and control to reduce the economic losses caused by DHAV to the waterfowl breeding industry. We screened five electronic research databases and obtained 14 studies and patents on the protection efficiency of DHAV-1 and DHAV-3 vaccines.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Meta-analysis demonstrated that immunized ducklings produced higher antibody levels and had a significantly higher survival rate than non-immunized ducklings [relative risk (RR) = 12, 95% confidence interval (CI) 6-26, P &lt; 0.01]. The age of the ducks and vaccine valence did not affect protection efficiency. Data source analysis of the vaccine protection rate demonstrated that the vaccines conferred immune protection for ducklings in both small-scale experiments and large-scale clinical conditions. The analysis results revealed that although the vaccines conferred protection, the immune protective effect differed between small-scale experimental conditions and large-scale clinical conditions. This might have been due to non-standard vaccination and environmental factors.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Domestic DHAV vaccines can protect ducklings effectively. The subjects immunized (breeding ducks or ducklings) and vaccine valence had no effect on the protective effect. Both small-scale experiments and large-scale clinical conditions conferred immune protection on ducklings, but vaccine immunization under small-scale experimental conditions had slightly better protective effects than large-scale clinical immunization.</AbstractText><CopyrightInformation>© 2023. BioMed Central Ltd., part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ye</LastName><ForeName>Lina</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Institute of Comparative Medicine, College of Veterinary Medicine, Yangzhou University, Yangzhou, 225009, Jiangsu, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Jiangsu Co-innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, Yangzhou, 225009, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Siyu</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institute of Comparative Medicine, College of Veterinary Medicine, Yangzhou University, Yangzhou, 225009, Jiangsu, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Jiangsu Co-innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, Yangzhou, 225009, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Huiling</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Health Pharmacy, New York, NY, 10013, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Tangjie</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Institute of Comparative Medicine, College of Veterinary Medicine, Yangzhou University, Yangzhou, 225009, Jiangsu, China. slx@yzu.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Jiangsu Co-innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, Yangzhou, 225009, Jiangsu, China. slx@yzu.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Daiqi</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Institute of Comparative Medicine, College of Veterinary Medicine, Yangzhou University, Yangzhou, 225009, Jiangsu, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Jiangsu Co-innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, Yangzhou, 225009, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hong</LastName><ForeName>Xingping</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Institute of Comparative Medicine, College of Veterinary Medicine, Yangzhou University, Yangzhou, 225009, Jiangsu, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Jiangsu Co-innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, Yangzhou, 225009, Jiangsu, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>the 111 Project D18007</GrantID><Agency>A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)</Agency><Country /></Grant><Grant><GrantID>the 111 Project D18007</GrantID><Agency>A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)</Agency><Country /></Grant><Grant><GrantID>the 111 Project D18007</GrantID><Agency>A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)</Agency><Country /></Grant><Grant><GrantID>the 111 Project D18007</GrantID><Agency>A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)</Agency><Country /></Grant><Grant><GrantID>the 111 Project D18007</GrantID><Agency>A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>09</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Vet Res</MedlineTA><NlmUniqueID>101249759</NlmUniqueID><ISSNLinking>1746-6148</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014612">Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004371" MajorTopicYN="Y">Hepatitis Virus, Duck</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006524" MajorTopicYN="Y">Hepatitis, Viral, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010850" MajorTopicYN="Y">Picornaviridae Infections</DescriptorName><QualifierName UI="Q000662" MajorTopicYN="N">veterinary</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014612" MajorTopicYN="Y">Vaccines</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName><QualifierName UI="Q000662" MajorTopicYN="N">veterinary</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004372" MajorTopicYN="N">Ducks</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011201" MajorTopicYN="Y">Poultry Diseases</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Duck</Keyword><Keyword MajorTopicYN="N">Duck hepatitis a virus</Keyword><Keyword MajorTopicYN="N">Mainland China</Keyword><Keyword MajorTopicYN="N">Meta-analysis</Keyword><Keyword MajorTopicYN="N">Vaccine protection rate</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>9</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>10</Month><Day>2</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>29</Day><Hour>18</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>29</Day><Hour>12</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>9</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37773135</ArticleId><ArticleId IdType="pmc">PMC10540391</ArticleId><ArticleId IdType="doi">10.1186/s12917-023-03744-8</ArticleId><ArticleId IdType="pii">10.1186/s12917-023-03744-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Chen P. Veterinary lemology. 6. China: China Agr; 2015. pp. 406–9.</Citation></Reference><Reference><Citation>Yugo D, Hauck R, ShivaprasadHL, Meng XJ. Hepatitis Virus Infections in Poultry. Avian Dis. 2016; 60(3): 576 – 88. 10.1637/11229-070515-Review.1.</Citation><ArticleIdList><ArticleId IdType="pubmed">27610716</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim MC, Kim MJ, Kwon YK, Lindberg AM, Joh SJ. Development of duck hepatitis a virus type 3 vaccine and its use to protect ducklings against infections. Vaccine. 2009;27(48):6688–94. doi: 10.1016/j.vaccine.2009.08.092.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2009.08.092</ArticleId><ArticleId IdType="pubmed">19747575</ArticleId></ArticleIdList></Reference><Reference><Citation>Levine PP, Fabricant J. A hitherto-undescribed virus disease of duck in North America. Cornell Vet. 1950;40(1):71–86.</Citation></Reference><Reference><Citation>Tseng CH, Tsai HJ. Molecular characterization of a new serotype of duck hepatitis virus. Virus Res. 2007;126(1–2):19–31. doi: 10.1016/j.virusres.2007.01.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2007.01.012</ArticleId><ArticleId IdType="pubmed">17292992</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang LY, Pan M, Fu Y, Zhang DB. Classification of duck hepatitis virus into three genotypes based on molecular evolutionary analysis. Virus Genes. 2008;37(1):52–9. doi: 10.1007/s11262-008-0233-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11262-008-0233-1</ArticleId><ArticleId IdType="pubmed">18437547</ArticleId></ArticleIdList></Reference><Reference><Citation>Koci MD, Schultz-Cherry S. Avian astroviruses. Avian Pathol. 2002;31(3):213–27. doi: 10.1080/03079450220136521.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/03079450220136521</ArticleId><ArticleId IdType="pubmed">12396344</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu N, Wang FM, Shi JJ, Zheng LS, Wang XY, Zhang DB. Molecular characterization of a duck hepatitis virus 3-like astrovirus. Vet Microbiol. 2014;170(1–2):39–47. doi: 10.1016/j.vetmic.2014.01.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vetmic.2014.01.026</ArticleId><ArticleId IdType="pubmed">24560589</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin SL, Cong RC, Zhang RH, Chen JH, Xia LL, Xie ZJ, et al. Circulation and in vivo distribution of duck hepatitis a virus types 1 and 3 in infected ducklings. Arch Virol. 2016;161(2):405–16. doi: 10.1007/s00705-015-2648-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-015-2648-z</ArticleId><ArticleId IdType="pubmed">26597185</ArticleId></ArticleIdList></Reference><Reference><Citation>Niu YJ, Ma HY, Ding YH, Li ZQ, Sun YC, Li MH, et al. The pathogenicity of duck hepatitis a virus types 1 and 3 on ducklings. Poult Sci. 2019;98(12):6333–9. doi: 10.3382/ps/pez455.</Citation><ArticleIdList><ArticleId IdType="doi">10.3382/ps/pez455</ArticleId><ArticleId IdType="pmc">PMC8913754</ArticleId><ArticleId IdType="pubmed">31393586</ArticleId></ArticleIdList></Reference><Reference><Citation>Announcement N. 1959 of the Ministry of Agriculture of the PRC. MOA.2013. https://www.moa.gov.cn/gk/tzgg_1/gg/201307/t20130702_3509497.htm. Accessed 02 July 2013.</Citation></Reference><Reference><Citation>Announcement N. 1904 of the Ministry of Agriculture of the PRC. MOA.2013.https://www.moa.gov.cn/govpublic/SYJ/201303/t20130305_3238250.htm. Accessed 05 March 2013.</Citation></Reference><Reference><Citation>Zhu YD. Effect of duck hepatitis A virus type 1 attenuated vaccine on replication and pathogenicity of type 3 virulent virus in ducklings. Dissertation. Sichuan Agric. Univ; 2018.</Citation></Reference><Reference><Citation>Li ZH, Wang MX, Wang XY, Zhang B, Zhang DB. Virulence conversion test of duck hepatitis gene type 3 attenuated vaccine strain. The 19th Academic Seminar of Avian Diseases Branch of 2018 Academic Annual Meeting(CAAV 2018), Nanning, China, 22–24 November 2018; 100. https://kns.cnki.net/kcms/detail/detail.aspx?dbcode=CPFD&amp;dbname=CPFDLAST2019&amp;filename=ZGXJ201811003069&amp;uniplatform=NZKPT&amp;v=b36SEmA04oP5I_zQrxhzZEq9BkGTBVNGdjv1C2zjnJO5KlVJQVtcE5EA8P5clUAZ5Wo1qbvgiUI%3d.</Citation></Reference><Reference><Citation>Song SS, Li PF, Zhang RH, Chen JH, Lan JJ, Lin SL, et al. Oral vaccine of recombinant Lactococcus lactis expressing the VP1 protein of duck hepatitis a virus type 3 induces mucosal and systemic immune responses. Vaccine. 2019;37(31):4364–9. doi: 10.1016/j.vaccine.2019.06.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2019.06.026</ArticleId><ArticleId IdType="pubmed">31227355</ArticleId></ArticleIdList></Reference><Reference><Citation>Niu YJ, Liu BH, Sun C, Zhao LL, Chen HY. Construction of the recombinant duck enteritis virus delivering capsid protein VP0 of the duck hepatitis a virus. Vet Microbiol. 2020;249:108837. doi: 10.1016/j.vetmic.2020.108837.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vetmic.2020.108837</ArticleId><ArticleId IdType="pubmed">32947184</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang AP, Gu LL, Wu S, Zhu SY. Duck hepatitis a virus structural proteins expressed in insect cells self-assemble into virus-like particles with strong immunogenicity in ducklings. Vet Microbiol. 2018;215:23–8. doi: 10.1016/j.vetmic.2017.12.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vetmic.2017.12.020</ArticleId><ArticleId IdType="pubmed">29426402</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang M, Roh JH, Jang HK. Protective efficacy of a bivalent live attenuated vaccine against duck hepatitis a virus types 1 and 3 in ducklings. Vet. Microbiol. 2018;214:108–12. doi: 10.1016/j.vetmic.2017.12.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vetmic.2017.12.018</ArticleId><ArticleId IdType="pubmed">29408021</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng AC, Wang MS, Zhu DK, Chen XY. Attenuated CH60 strain of duck hepatitis virus and its live attenuated vaccine. China Patent CN103103163A.11 Jan 2013. https://d.wanfangdata.com.cn/patent/ChJQYXRlbnROZXdTMjAyMjAzMjMSEENOMjAxMzEwMDExODcyLjMaCHJzeTdycWVs.</Citation></Reference><Reference><Citation>Fan SC, Li H, Yan TK, Yuan SZ, Xie BC, Zhang B et al. A bivalent inactivated vaccine against duck viral hepatitis. China Patent CN102895660A.25 Oct 2012. https://d.wanfangdata.com.cn/patent/ChJQYXRlbnROZXdTMjAyMjAzMjMSEENOMjAxMjEwNDE0MDE3LjIaCGJpanZvanJv.</Citation></Reference><Reference><Citation>He QX. The clinical immune experimental study on attenuated living vaccine of duck viral hepatitis. Dissertation. Sichuan Agr. Uni.; 2010. https://t.cnki.net/kcms/detail?v=3uoqIhG8C475KOm_zrgu4lQARvep2SAkhskYGsHyiXlyV6jw0YcPLB0KmyV0zkR5IunGr3TzuRgYiIqA57P21fqb-DTyddhr&amp;uniplatform=NZKPT.</Citation></Reference><Reference><Citation>Liu WJ, Li J, ZhangS, Zhang WL, Fan GB. An Inactivated Duck Hepatitis Vaccine and its preparation and application. China Patent CN201410834435.6. 26 Dec 2014. https://d.wanfangdata.com.cn/patent/ChJQYXRlbnROZXdTMjAyMjAzMjMSEENOMjAxNDEwODM0NDM1LjYaCG03eDVmcnd1.</Citation></Reference><Reference><Citation>Song Y, Zang YT, Zheng TX, Yin YD, Guo J, Liang WN et al. Inactivated bivalent vaccine against duck viral hepatitis and its preparation. China Patent CN106177938A.30 Aug 2016. https://d.wanfangdata.com.cn/patent/ChJQYXRlbnROZXdTMjAyMjAzMjMSEENOMjAxNjEwNzgxNTEyLjUaCGFuazE1bDZj.</Citation></Reference><Reference><Citation>Su JL, Han XM, Zhang QS, Qi SH, Zhu CH, Xiao AF et al. A chicken embryo attenuated strain of duck hepatitis a virus type III and its application. China Patent CN109504664A.14 Sept, 2017.https://d.wanfangdata.com.cn/patent/ChJQYXRlbnROZXdTMjAyMjAzMjMSEENOMjAxNzEwODI1NjA0LjMaCDZvMjF5dzZr.</Citation></Reference><Reference><Citation>Wei SY, Zhao GW. Preparation of inactivated vaccine with muscovy duck hepatitis virus. China Patent CN105854009A.03 May2016. https://d.wanfangdata.com.cn/patent/ChJQYXRlbnROZXdTMjAyMjAzMjMSEENOMjAxNjEwMjg1MDk5LjMaCHNjM3YxcDE5.</Citation></Reference><Reference><Citation>Wen XJ, Cheng AC, Wang MS. A mutant gene ISA-A117C-C4334A of duck hepatitis a virus type 3 and its construction. China Patent CN110295180A.21 Aug 2019. https://d.wanfangdata.com.cn/patent/ChJQYXRlbnROZXdTMjAyMjAzMjMSEENOMjAxOTEwNTUxMDk1LjkaCGJ5Z2J6dTFu.</Citation></Reference><Reference><Citation>Zhang JQ, Liu HT, Yang AB, Li YH, Shang SW, Wang WW, et al. Protection of duck viral hepatitis bivalent (Yb3 + GD) inactivated vaccine against duck viral hepatitis epidemic strain. Shandong J Anim Husb Vet. 2018;39(4):6–7.</Citation></Reference><Reference><Citation>Zhang XF. Development of attenuated duck viral hepatitis vaccine (A66 strain). Dissertation. Nanjing Agric Univ, Nanjing; 2010.</Citation></Reference><Reference><Citation>Zhang XF, Lu FY, Ding MJ, Huang XM, Li HD. Serum type 3 live duck hepatitis a virus vaccine and its preparation method. China Patent CN104726414A.07 Jan 2015. https://d.wanfangdata.com.cn/patent/ChJQYXRlbnROZXdTMjAyMjAzMjMSEENOMjAxNTEwMDA2NjQ2LjUaCGlrMXY4YmQ4.</Citation></Reference><Reference><Citation>Chen SL, Liu YX, Shu XW, Li H, Wu GC, Lu MF et al. A duck hepatitis virus vaccine strain, vaccine and vaccine preparation method. China Patent CN202011299990.5.18 Nov 2020. https://d.wanfangdata.com.cn/patent/ChJQYXRlbnROZXdTMjAyMjAzMjMSEENOMjAyMDExMjk5OTkwLjUaCG92OXI2bGI4.</Citation></Reference><Reference><Citation>Zhang XK, Sun JZ, Qiao RC. Duck hepatitis virus strain and inactivated vaccine. China Patent CN201010273200.6.02 Sept 2010. https://d.wanfangdata.com.cn/patent/ChJQYXRlbnROZXdTMjAyMjAzMjMSEENOMjAxMDEwMjczMjAwLjYaCGt6emVrajNy.</Citation></Reference><Reference><Citation>Wu FY, Lu FY, Fan X, Pan QX, Zhao S, Sun HW, et al. Development of a live attenuated duck hepatitis a virus type 3 vaccine (strain SD70) Vaccine. 2020;38(30):4695–703. doi: 10.1016/j.vaccine.2020.05.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2020.05.030</ArticleId><ArticleId IdType="pubmed">32446833</ArticleId></ArticleIdList></Reference><Reference><Citation>YinFG, Li J, Zhang S, Yu M, ZhangWL, FanGB, et al. Development and evaluation of an inactivated bivalentvaccine against duck viral hepatitis. Chin J Biotech. 2015;31(11):1579–88.</Citation><ArticleIdList><ArticleId IdType="pubmed">26939441</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou Z, Ma J, Huang K, Chen HC, Liu ZD, Jin ML. Live attenuated vaccine based on duck enteritis virus against duck Hepatitis A Virus types 1 and 3. Front Microbiol. 2016;7:1613. doi: 10.3389/fmicb.2016.01613.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2016.01613</ArticleId><ArticleId IdType="pmc">PMC5056193</ArticleId><ArticleId IdType="pubmed">27777571</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang SY, Wang MS, Zhang B, Feng YL, Tang J, Xie M et al. NOD1 is Associated with the susceptibility of Pekin duck flock to duck Hepatitis A Virus genotype 3. Front Immunol. 2021; 12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8563994</ArticleId><ArticleId IdType="pubmed">34745142</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang YY, Wu S, Liu WB, Hu ZL. Current status and future direction of duck hepatitis a virus vaccines. Avian Pathol. 2023;52(2):89–99. doi: 10.1080/03079457.2022.2162367.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/03079457.2022.2162367</ArticleId><ArticleId IdType="pubmed">36571394</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiang M, Zhang HR, Yue H, Ren YP, Xiang H, Isolation Identification and whole genome sequencing analysis of four gene type C duck Hepatitis a virus strains in Sichuan Province. Chin J Prev Vet Med. 2021;43(1):14–20.</Citation></Reference><Reference><Citation>Tao HJ, Li HW. Immunoprotective Test of Duck Hepatitis Virus Henan Strain. J. Zhengzhou Anim.Husb. Eng. Coll. 2014; 34(1):16–18. https://kns.cnki.net/kcms2/article/abstract?v=3uoqIhG8C44YLTlOAiTRKgchrJ08w1e7M8Tu7YZds89UxouKCuSO8r75p-lfxY7Ue7G47OsQ75ojYEqjlg4HhAzu500S67D3&amp;uniplatform=NZKPT.</Citation></Reference><Reference><Citation>Han XM, Ma JJ, Gao JF, Wu BQ, Zhang BZ, Lai Z. Diagnosis of duck viral hepatitis type 3 and isolation and identification of the virus. Chin J Vet Med. 2019;55(12):60–2.</Citation></Reference><Reference><Citation>Lin SL, Cong RC, Zhang RH, Chen JH, Xia LL, Xie ZJ, et al. Circulation and in vivo distribution of duck hepatitis Avirus types 1 and 3 in infected ducklings. Arch Virol. 2016;161(2):405–16. doi: 10.1007/s00705-015-2648-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-015-2648-z</ArticleId><ArticleId IdType="pubmed">26597185</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen X, Zhu D, Cheng A, Wang M, Chen S, Jia R, et al. Molecular epidemiology of duck hepatitis a virus types1 and 3 in China, 2010–2015. Transbound Emerg Dis. 2018;65(1):10–5. doi: 10.1111/tbed.12741.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/tbed.12741</ArticleId><ArticleId IdType="pubmed">29076646</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai HJ, Swayne DE. Duck hepatitis. Diseases of poultry.2020; 450–460.</Citation></Reference><Reference><Citation>Zhang X, Zhang R, Wang J, Sui N, Xu G, Yan H, et al. Construction of recombinant Lactococcus lactis strain expressing VP1 fusion protein of duck hepatitis a virus type 1 and evaluation of its immune effect. Vaccines. 2021;9(12):1479. doi: 10.3390/vaccines9121479.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines9121479</ArticleId><ArticleId IdType="pmc">PMC8709260</ArticleId><ArticleId IdType="pubmed">34960225</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou SY, Li S, Wang YS, Li XW, Zhang TJ. Duck hepatitis a virus prevalence in mainland China between 2009 and 2021: a systematic review and meta-analysis. Prev Vet Med. 2022;208:105730. doi: 10.1016/j.prevetmed.2022.105730.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.prevetmed.2022.105730</ArticleId><ArticleId IdType="pubmed">35964373</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma C, Liu K, Chen H, Liu T, Wang R, Chen K. Survey on immunization of duck Virus Hepatitisof meat duck in Xinyang of Henan Province[Chinese] PoultSci. 2014;2:50–2.</Citation></Reference><Reference><Citation>Woolcock PR, Crighton GW. Duck virus hepatitis: serial passage of attenuated virus in ducklings. Vet Rec. 1979;105(2):30–2. doi: 10.1136/vr.105.2.30.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/vr.105.2.30</ArticleId><ArticleId IdType="pubmed">233456</ArticleId></ArticleIdList></Reference><Reference><Citation>Hooijmans CR, Rovers MM, de Vries RBM, Leenaars M, Ritskes-Hoitinga M, Langendam MW. SYRCLE’s risk of bias tool for animal studies. Bmc Med Res Methodol. 2014; 14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4230647</ArticleId><ArticleId IdType="pubmed">24667063</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539–58. doi: 10.1002/sim.1186.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.1186</ArticleId><ArticleId IdType="pubmed">12111919</ArticleId></ArticleIdList></Reference><Reference><Citation>Woody CA, Ferrari AJ, Siskind DJ, Whiteford HA, Harris MG. A systematic review and meta-regression of the prevalence and incidence of perinatal depression. J Affect Disord. 2017;219:86–92. doi: 10.1016/j.jad.2017.05.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jad.2017.05.003</ArticleId><ArticleId IdType="pubmed">28531848</ArticleId></ArticleIdList></Reference><Reference><Citation>Petitti DB. Approaches to heterogeneity in meta-analysis. Stat Med. 2001;20(23):3625–33. doi: 10.1002/sim.1091.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.1091</ArticleId><ArticleId IdType="pubmed">11746342</ArticleId></ArticleIdList></Reference><Reference><Citation>Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629–34. doi: 10.1136/bmj.315.7109.629.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.315.7109.629</ArticleId><ArticleId IdType="pmc">PMC2127453</ArticleId><ArticleId IdType="pubmed">9310563</ArticleId></ArticleIdList></Reference><Reference><Citation>Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50(4):1088–101. doi: 10.2307/2533446.</Citation><ArticleIdList><ArticleId IdType="doi">10.2307/2533446</ArticleId><ArticleId IdType="pubmed">7786990</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>